RNAC
Cartesian Therapeutics, Inc.
+0.11 (+1.39%)8.02USD38.6K成交股數243M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00 | 0.00-100% | 0.00 | 0.00-100% | 0.00-100% | 400K-95% | 0.00-100% | 33.3M+534% | 5.8M | 8.3M | 6.6M | 5.2M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 20.4M | 19.5M | 14.7M | 13.8M | 14.9M | 14.7M | 11.4M | 12.7M | 9.7M | 21.9M | 13.0M | 17.8M |
| 銷售管理費用 | 8.7M | 7.1M | 8.2M | 7.7M | 7.2M | 8.3M | 6.6M | 7.0M | 9.5M | 22.0M | 6.6M | 6.1M |
| 營業利益 | −29.2M+34% | −26.5M+21% | −78.6M+347% | −21.1M-253% | −21.8M+63% | −21.9M-40% | −17.6M+35% | 13.8M-174% | −13.3M | −36.3M | −13.1M | −18.6M |
| 營業利益率 | – | – | – | – | – | -5,472.3% | – | 41.3% | -228.6% | -439.5% | -199.4% | -355.1% |
| 稅後淨利 | 15.8M-1% | −39.2M+121% | −92.6M+283% | −35.9M-359% | 15.9M-128% | −17.7M-90% | −24.2M+169% | 13.8M-222% | −56.8M | −178M | −9.0M | −11.4M |
| 淨利率 | – | – | – | – | – | -4,427.5% | – | 41.6% | -973.0% | -2,149.3% | -137.4% | -216.9% |
| 稀釋 EPS | 0.46-8% | -1.46+115% | -3.46+206% | -1.38-356% | 0.50-105% | -0.68-98% | -1.13-35% | 0.54-124% | -10.50 | -41.55 | -1.74 | -2.23 |
| 稀釋股數 | 29.9M | 26.9M | 26.0M | 26.0M | 26.4M | 25.9M | 21.5M | 17.8M | 5.4M | 5.2M | 5.2M | 5.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 148M | 119M | 125M | 143M | 160M | 180M | 219M | 87.2M | 103M | 76.9M | 79.6M | 112M |
| 應收帳款 | 196K | 261K | 1.1M | 722K | 354K | 1.8M | 4.8M | 32.0M | 2.0M | 5.9M | 4.9M | 5.4M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 319M | 288M | 296M | 373M | 389M | 409M | 455M | 348M | 325M | 305M | 106M | 140M |
| 有息負債 | 52.9M | – | 0.00 | – | – | – | – | – | – | – | – | – |
| 總負債 | 444M | 437M | 423M | 409M | 391M | 431M | 455M | 449M | 442M | 445M | 45.7M | 74.1M |
| 股東權益 | −125M | −148M | −126M | −35.8M | −2.5M | −21.8M | 752K | −101M | −117M | −440M | 60.3M | 65.4M |
| 負債比 | 139.3% | 151.4% | 142.6% | 109.6% | 100.6% | 105.3% | 99.8% | 129.2% | 135.9% | 145.8% | 43.1% | 53.1% |
| 淨現金(現金 − 有息負債) | 94.8M | – | 125M | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −22.1M-4% | – | – | – | −23.1M | – | – | −15.9M | – | – | – |
| 資本支出 | – | 27K | – | – | – | 1.1M | – | – | 602K | – | – | – |
| 自由現金流 | – | −22.2M-8% | – | – | – | −24.2M | – | – | −16.5M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | -6,045.8% | – | – | -282.9% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 400K
| Operating | 400K | 100.0% | -99.0% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 400K | -99.0% | −130M | -32,575.5% | -5.02 | −79.4M |
| FY2024 | 38.3M | +47.2% | −77.4M | -202.3% | -4.49 | −32.8M |
| FY2023 | 26.0M | -76.5% | −220M | -844.9% | -49.76 | −51.4M |
| FY2022 | 111M | +30.2% | 35.4M | 31.9% | 0.10 | −32.8M |
| FY2021 | 85.1M | +412.6% | −25.7M | -30.2% | -0.22 | −61.5M |
| FY2020 | 16.6M | +148.6% | −68.9M | -415.0% | -0.68 | 34.1M |
| FY2019 | 6.7M | +639.4% | −55.4M | -829.0% | -1.22 | −51.5M |
| FY2018 | 903K | – | −65.3M | -7,235.4% | -2.92 | −60.0M |